Patrick Biggar

619 total citations
25 papers, 375 citations indexed

About

Patrick Biggar is a scholar working on Nephrology, Hematology and Nutrition and Dietetics. According to data from OpenAlex, Patrick Biggar has authored 25 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 8 papers in Hematology and 7 papers in Nutrition and Dietetics. Recurrent topics in Patrick Biggar's work include Parathyroid Disorders and Treatments (11 papers), Erythropoietin and Anemia Treatment (8 papers) and Iron Metabolism and Disorders (7 papers). Patrick Biggar is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Erythropoietin and Anemia Treatment (8 papers) and Iron Metabolism and Disorders (7 papers). Patrick Biggar collaborates with scholars based in Germany, United Kingdom and United States. Patrick Biggar's co-authors include Markus Ketteler, Orfeas Liangos, Richard F. Pollock, H. Rothe, Gheun‐Ho Kim, Thilo Krüger, Georg Schlieper, Arndt T. Petermann, Johannes Rieber and Martin Schmidt and has published in prestigious journals such as The American Journal of Cardiology, Nephrology Dialysis Transplantation and Nature Reviews Nephrology.

In The Last Decade

Patrick Biggar

25 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Biggar Germany 12 196 99 67 63 58 25 375
Belinda J. Schouten New Zealand 7 215 1.1× 96 1.0× 24 0.4× 77 1.2× 41 0.7× 9 355
H P Krohn Germany 9 125 0.6× 58 0.6× 25 0.4× 49 0.8× 88 1.5× 16 420
Evelyn Alonzo Venezuela 9 130 0.7× 93 0.9× 14 0.2× 38 0.6× 89 1.5× 10 360
Ken Iseri Japan 15 327 1.7× 52 0.5× 23 0.3× 20 0.3× 88 1.5× 38 576
Konstantin Gurevich United States 6 234 1.2× 156 1.6× 11 0.2× 58 0.9× 30 0.5× 8 399
Elizabeth Ireland United States 3 369 1.9× 62 0.6× 17 0.3× 100 1.6× 75 1.3× 3 446
Osamu Matsumura Japan 10 135 0.7× 176 1.8× 17 0.3× 54 0.9× 66 1.1× 29 426
N. Settefrati Italy 8 133 0.7× 108 1.1× 40 0.6× 15 0.2× 80 1.4× 11 359
Kenneth S. Kleinman United States 7 251 1.3× 84 0.8× 21 0.3× 29 0.5× 35 0.6× 8 409
Elizabeth A. Swallow United States 12 204 1.0× 36 0.4× 20 0.3× 44 0.7× 28 0.5× 32 325

Countries citing papers authored by Patrick Biggar

Since Specialization
Citations

This map shows the geographic impact of Patrick Biggar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Biggar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Biggar more than expected).

Fields of papers citing papers by Patrick Biggar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Biggar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Biggar. The network helps show where Patrick Biggar may publish in the future.

Co-authorship network of co-authors of Patrick Biggar

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Biggar. A scholar is included among the top collaborators of Patrick Biggar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Biggar. Patrick Biggar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Nicholas A., et al.. (2023). A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose. International Journal of Clinical Pharmacy. 45(3). 604–612. 10 indexed citations
2.
Pollock, Richard F. & Patrick Biggar. (2020). Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert Review of Hematology. 13(2). 187–195. 35 indexed citations
3.
Biggar, Patrick, et al.. (2019). Needs Around Dialysis Treatment from Different Perspectives (NADIP): Results of the Exploratory German Multicenter Survey. Kidney & Blood Pressure Research. 44(5). 1233–1246. 2 indexed citations
4.
Dahlem, Peter & Patrick Biggar. (2017). Follow-up of Newborns, Infants, and Children with Sepsis. 7(1). e38–e41. 1 indexed citations
5.
Ketteler, Markus, Orfeas Liangos, & Patrick Biggar. (2016). Treating hyperphosphatemia – current and advancing drugs. Expert Opinion on Pharmacotherapy. 17(14). 1873–1879. 14 indexed citations
6.
Biggar, Patrick, Samuel Fung, & Markus Ketteler. (2014). Treatment of phosphate retention: The earlier the better?. Kidney Research and Clinical Practice. 33(1). 3–8. 2 indexed citations
7.
8.
Ketteler, Markus & Patrick Biggar. (2013). Use of phosphate binders in chronic kidney disease. Current Opinion in Nephrology & Hypertension. 22(4). 413–420. 23 indexed citations
9.
Biggar, Patrick & Markus Ketteler. (2013). ESA therapy the quest continues: anemia treatment following recent national and international recommendations 2011 and 2012. Clinical Nephrology. 79(5). 335–350. 4 indexed citations
10.
Biggar, Patrick, et al.. (2013). [Importance of the different i.v. iron generations for everyday medical practice].. PubMed. 155 Suppl 1. 18–24. 3 indexed citations
11.
Biggar, Patrick, et al.. (2013). Bedeutung der verschiedenen i.v.-Eisengenerationen für den medizinischen Alltag. MMW - Fortschritte der Medizin. 155(S2). 18–24. 7 indexed citations
12.
Ketteler, Markus, Patrick Biggar, & Orfeas Liangos. (2012). FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease. Nephrology Dialysis Transplantation. 28(4). 821–825. 23 indexed citations
13.
Ketteler, Markus, H. Rothe, Thilo Krüger, Patrick Biggar, & Georg Schlieper. (2011). Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nature Reviews Nephrology. 7(9). 509–516. 57 indexed citations
14.
Rittger, Harald, Johannes Rieber, Anil M. Sinha, et al.. (2010). Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clinical Research in Cardiology. 100(5). 439–446. 20 indexed citations
15.
Biggar, Patrick, et al.. (2010). Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug?. Pediatric Nephrology. 26(1). 7–18. 23 indexed citations
16.
Biggar, Patrick & Markus Ketteler. (2010). Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III – V). Expert Opinion on Pharmacotherapy. 11(16). 2739–2750. 7 indexed citations
17.
Schmidt, Martin, Johannes Rieber, Marcos Daccarett, et al.. (2009). Relation of Recurrence of Atrial Fibrillation After Successful Cardioversion to Renal Function. The American Journal of Cardiology. 105(3). 368–372. 34 indexed citations
18.
Ketteler, Markus & Patrick Biggar. (2009). Dietary and Pharmacological Control of Calcium and Phosphate Metabolism in Predialysis Stages of Chronic Kidney Disease. Blood Purification. 27(4). 345–349. 5 indexed citations
19.
Ketteler, Markus & Patrick Biggar. (2009). Review article: Getting the balance right: Assessing causes and extent of vascular calcification in chronic kidney disease. Nephrology. 14(4). 389–394. 26 indexed citations
20.
Biggar, Patrick, et al.. (2008). Switch of ESA therapy from darbepoetin-? to epoetin-? in hemodialysis patients: a single-center experience. Clinical Nephrology. 69(3). 185–192. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Belinda J. Schouten Breakdown of academic impact, for papers by H P Krohn Breakdown of academic impact, for papers by Evelyn Alonzo Breakdown of academic impact, for papers by Ken Iseri Breakdown of academic impact, for papers by Konstantin Gurevich Breakdown of academic impact, for papers by Elizabeth Ireland Breakdown of academic impact, for papers by Osamu Matsumura Breakdown of academic impact, for papers by N. Settefrati Breakdown of academic impact, for papers by Kenneth S. Kleinman Breakdown of academic impact, for papers by Elizabeth A. Swallow
Rankless by CCL
2026